<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To determine the prevalence and effects of <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e> on metabolic control in a Cameroonian diabetic population in a tertiary care setup </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This was a cross-sectional study involving 73 consecutive outpatients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> recruited from the Yaounde National <z:mp ids='MP_0002055'>Diabetes</z:mp> and <z:hpo ids='HP_0001513'>Obesity</z:hpo> Centre </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">Sickle cell trait</z:e> status was based on <z:chebi fb="34" ids="35143">haemoglobin</z:chebi> electrophoresis </plain></SENT>
<SENT sid="3" pm="."><plain>Metabolic control was assessed by plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and HbA(1c), and comparisons made between participants with and without <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e>, with adjustment for confounders through linear regressions models </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e> was 19%, without sex difference, and comparable with figures in individuals without <z:mp ids='MP_0002055'>diabetes</z:mp> in this setting </plain></SENT>
<SENT sid="5" pm="."><plain>Participants with <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e> were older than the non-trait participants (66 vs. 58 years, P = 0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>Otherwise, clinical and biological profile including indicators of metabolic control were similarly distributed between trait and non-trait participants (<z:hpo ids='HP_0000001'>all</z:hpo> P &gt;0.08) </plain></SENT>
<SENT sid="7" pm="."><plain>After adjustment for confounders, <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e> was unrelated to fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (β = 0.02; 95% confidence interval -37.68-43.30) and HbA(1c) (β = -0.03, 95% confidence interval -1.18-0.93), and did not affect the relationship between the two markers of <z:mp ids='MP_0002055'>diabetes</z:mp> control (β = -0.03, 95% confidence interval -1.18-0.89) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">Sickle cell trait</z:e> was as frequent in this subgroup of patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> as in the general population, suggesting no specific association with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>It does not affect the metabolic control of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>However, how this translates into long-term outcome needs to be fully elucidated in this setting, with an increasing population with both <z:e sem="disease" ids="C0037054" disease_type="Disease or Syndrome" abbrv="">sickle cell trait</z:e> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
</text></document>